SciClone Pharmaceuticals, Inc. (SCLN) reported net income for the fourth quarter of $1.9 million or $0.03 per share, compared to $11.6 million or $0.19 per share for the year-ago quarter.
Excluding items, adjusted net income for the fourth quarter was $2.0 million or $0.04 per share, compared to $11.4 million or $0.19 per share in the prior year quarter.
Total net revenue for the fourth quarter fell to $33.14 million form $39.68 million a year ago.
Analysts polled by Thomson Reuters expected the company to earn $0.12 per share on revenue of $35.30 million for the fourth quarter. Analysts' estimates typically exclude special items.
Looking forward to full year 2013, the company forecast revenue of $150 to $155 million and adjusted earnings of $0.66 and $0.72 per share. Analysts currently expect the company to earn $0.65 per share on revenue of $153.07 million for the full year 2013.
For comments and feedback: editorial@rttnews.com